Production (Stage)
Mustang Bio, Inc.
MBIO
$1.24
-$0.01-0.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 645.74% | -115.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1,073.08% | -101.78% | |||
| Operating Income | -1,073.08% | 101.78% | |||
| Income Before Tax | 83.93% | 32.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 83.93% | 32.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.93% | 32.48% | |||
| EBIT | -1,073.08% | 101.78% | |||
| EBITDA | -384.42% | 105.48% | |||
| EPS Basic | 94.32% | 50.82% | |||
| Normalized Basic EPS | -159.43% | 104.70% | |||
| EPS Diluted | 94.32% | 50.82% | |||
| Normalized Diluted EPS | -159.43% | 104.70% | |||
| Average Basic Shares Outstanding | 182.81% | 37.30% | |||
| Average Diluted Shares Outstanding | 182.81% | 37.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||